Armata Pharmaceuticals
(NYSEMKT) ARMP
Armata Pharmaceuticals Financials at a Glance
Market Cap
$156.39MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Revenue (TTM)
$2.96M
Net Income (TTM)
-$282.61M
EPS (TTM)
-$7.76
P/E Ratio
-0.55
Dividend
$0.00
Beta (Volatility)
0.40 (Low)
Dividend
$0.00
Beta (Volatility)
0.40 (Low)
Price
$4.17
Volume
4,725
Open
$4.73
Price
$4.17
Volume
4,725
Open
$4.73
Previous Close
$4.17
Daily Range
$4.17 - $4.76
52-Week Range
$2.14 - $16.34
Estimated Earnings Date
Aug 11, 2026
Dividend
$0.00
Beta (Volatility)
0.40 (Low)
Price
$4.17
Volume
4,725
Open
$4.73
Previous Close
$4.17
Daily Range
$4.17 - $4.76
52-Week Range
$2.14 - $16.34
Estimated Earnings Date
Aug 11, 2026
ARMP News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Armata Pharmaceuticals
Industry
Biotechnology
Sector
Health CareEmployees
61
CEO
Deborah L. Birx, MD
Website
www.armatapharma.comHeadquarters
Marina del Rey, CA 90292, US
ARMP Financials
Key Financial Metrics (TTM)
Gross Margin
72.18%
Operating Margin
-1258.55%
Net Income Margin
-9554.23%
Return on Equity
162.59%
Return on Capital
-44.97%
Return on Assets
-404.89%
Earnings Yield
-1.82%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$156.39MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Shares Outstanding
36.71M
Volume
4.72K
Avg. Volume
117.72K
Financials (TTM)
Gross Profit
$2.14M
Operating Income
-$37.23M
EBITDA
-$262.46M
Operating Cash Flow
-$23.97M
Capital Expenditure
-$506.00K
Free Cash Flow
-$24.47M
Cash & ST Invst.
$4.75M
Total Debt
$373.67M
Armata Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$789.00K
+60.7%
Gross Profit
$332.00K
+191.2%
Gross Margin
42.08%
N/A
Market Cap
$156.39MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
N/A
Market Cap/Employee
$2.61M
N/A
Employees
60
N/A
Net Income
-$115.35M
-1666.1%
EBITDA
-$109.33M
-4184.1%
Quarterly Fundamentals
Total Cash
$4.75M
-59.3%
Total Debt
$373.67M
+177.5%
Accounts Receivable
$47.00K
-80.3%
Inventory
$0.00
N/A
Long Term Debt
$369.08M
+1246.2%
Short Term Debt
$4.59M
-95.7%
Return on Assets
-4.05%
N/A
Return on Invested Capital
-61.46%
N/A
Free Cash Flow
-$5.85M
+23.9%
Operating Cash Flow
-$5.78M
+23.7%